The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial...

28
May 4, 2011 Via Electronic Transmission Steven C. Anderson, IOM, CAE President and Chief Executive Officer National Association of Chain Drug Stores 413 North Lee Street Alexandria, VA 22314 Dear Mr. Anderson: In December 2009, I asked for an accounting of industry funding that the National Association of Chain Drug Stores (NACDS) receives from pharmaceutical and medical device companies as well as foundations established by these companies or the insurance industry. I appreciate your response, which I have attached to this letter. I write today to follow up on any efforts by your organization to improve transparency and accountability in its relationships with the pharmaceutical and device industries. As I stated in my previous letter, I started my inquiry, in part, as a result of accounts documenting the lack of transparency in financial relationships between the pharmaceutical industry and nonprofit health and medical organizations. Specifically, I cited the April 2008 article in The Wall Street Journal, which reported that industry representatives, including ten major drug companies, had formed a coalition to promote looser restrictions on off-label marketing. 1 The coalition had asked the National Alliance on Mental Illness (NAMI) to speak in favor of this issue. In response to my concerns in my April 2009 letter to NAMI, NAMI began to voluntarily disclose to the public any amount of funding exceeding $5,000 that it received from pharmaceutical companies and foundations on its website. Further, NAMI began to provide a brief description of the purpose of the funding on its website. I commend NAMI for its leadership and had hoped that when I reached out to your organization and 32 others, your organization would follow NAMI’s example and begin posting similar funding information on NACDS’s website. As of the date of this letter, it appears that no additional information regarding your organization’s industry funding has been posted on the NACDS’s website. If NACDS is 1 Alicia Mundy, “Off-Label Use of Drugs Gets a Push --- Big Pharma Lobbies Washington to Relax Rules on Marketing,” The Wall Street Journal, April 18, 2008.

Transcript of The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial...

Page 1: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

May 4, 2011

Via Electronic Transmission

Steven C. Anderson, IOM, CAE

President and Chief Executive Officer

National Association of Chain Drug Stores

413 North Lee Street

Alexandria, VA 22314

Dear Mr. Anderson:

In December 2009, I asked for an accounting of industry funding that the National

Association of Chain Drug Stores (NACDS) receives from pharmaceutical and medical device

companies as well as foundations established by these companies or the insurance industry. I

appreciate your response, which I have attached to this letter. I write today to follow up on any

efforts by your organization to improve transparency and accountability in its relationships with

the pharmaceutical and device industries.

As I stated in my previous letter, I started my inquiry, in part, as a result of accounts

documenting the lack of transparency in financial relationships between the pharmaceutical

industry and nonprofit health and medical organizations. Specifically, I cited the April 2008

article in The Wall Street Journal, which reported that industry representatives, including ten

major drug companies, had formed a coalition to promote looser restrictions on off-label

marketing.1 The coalition had asked the National Alliance on Mental Illness (NAMI) to speak in

favor of this issue.

In response to my concerns in my April 2009 letter to NAMI, NAMI began to voluntarily

disclose to the public any amount of funding exceeding $5,000 that it received from

pharmaceutical companies and foundations on its website. Further, NAMI began to provide a

brief description of the purpose of the funding on its website. I commend NAMI for its

leadership and had hoped that when I reached out to your organization and 32 others, your

organization would follow NAMI’s example and begin posting similar funding information on

NACDS’s website.

As of the date of this letter, it appears that no additional information regarding your

organization’s industry funding has been posted on the NACDS’s website. If NACDS is

1 Alicia Mundy, “Off-Label Use of Drugs Gets a Push --- Big Pharma Lobbies Washington to Relax Rules on

Marketing,” The Wall Street Journal, April 18, 2008.

Page 2: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

currently taking steps to enhance the transparency of its financial relationships with the

pharmaceutical and device industries, I would appreciate information regarding those steps. If

not, please explain why your organization does not support the disclosure of funding it receives

from pharmaceutical and device companies.

The Medicare Payment Advisory Commission (MedPAC) recommended in a report to

Congress in March 2009 that Congress require that pharmaceutical and device companies report

their financial relationships with physician groups, patient organizations, and others. More

specifically MedPAC said the following:

Given the potential benefits of public reporting, we recommend that the Congress

mandate the reporting of comprehensive information on industry relationships

with physicians and other health care entities and that the Secretary post this

information on a public searchable website.2

MedPAC then went on to say in Recommendation 5-1 that:

The Congress should require all manufacturers and distributors of drugs,

biologicals, medical devices, and medical supplies (and their subsidiaries) to

report to the Secretary their financial relationship with:…physician groups and

other prescribers…patient organizations; and professional organizations.3

I look forward to working with you and other health and medical organizations to further

increase sunshine on financial relationships.

Thank you for your cooperation and attention in this matter. I would appreciate a

response by May 25, 2011. If you have any questions, please do not hesitate to contact Brian

Downey for the Committee on the Judiciary at (202) 224-5225.

Sincerely,

Charles E. Grassley

Ranking Member

Attachments

2 Medicare Payment Advisory Commission, “Public reporting of physicians’ financial relationships,” Report to

Congress: Medicare Payment Policy, March 2009. 3 Id.

Page 3: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

Attachment

Page 4: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

CONFIDENTIAL

January 27, 2010

Via Electronic Transmission The Honorable Charles E. Grassley Ranking Member Senate Committee On Finance Washington, DC 20510-6200 Dear Senator Grassley: Thank you for your letter of December 7, 2009, in which you requested certain financial data and other information from the National Association of Chain Drug Stores (NACDS). This letter and the attached charts provide the information you requested. NACDS is an independent organization that has advocated for chain pharmacies for over 75 years. We represent 158 traditional drug stores, supermarkets, and mass merchants with pharmacies – from regional chains with four stores to national companies. Chain pharmacies operate 37,000 pharmacies, and employ more than 2.5 million employees, including 118,000 full-time pharmacists. Our members fill more than 2.5 billion prescriptions annually, which is more than 72 percent of all prescriptions in the United States. NACDS also has almost 900 associate members. Associate members include pharmacy suppliers such as drug manufacturers, as well as many suppliers of nonmedical products such as cosmetics and greeting cards that are sold in the “front end” of the pharmacy. It is important to understand that NACDS represents chain pharmacies. Chain pharmacies control the policy making and decision making process at NACDS. Only companies that own or operate chain pharmacies are eligible to elect or serve on the NACDS Board of Directors and the NACDS Policy Council. Companies such as drug manufacturers, medical device manufacturers and insurance companies do not develop or control the policies and positions advocated by NACDS. NACDS collaborates with manufacturers and other suppliers when our policy positions are aligned, and NACDS remains free to disagree with those companies when our positions differ. The enclosed charts list the financial data you requested, including funds received by NACDS from drug manufacturers, medical device manufacturers, insurance companies and their foundations since January 2006. In an effort to ensure full transparency, we have included in the charts funding received from manufacturers of non-prescription drug products in addition to funding received from prescription drug manufacturers. The number of companies and the amount of funding included in the charts would be significantly smaller if manufacturers of over-the-counter medications were not included.

Page 5: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS Letter to Senator Charles Grassley January 27, 2010 Page 2

In addition to sponsorships, the enclosed charts include associate member dues payments. Associate member dues are capped at $9,960 per membership. The charts also include exhibit fees for booths at NACDS conferences. Although your staff indicated that we need not include conference registration fees in the charts, please be advised that the exhibit fees for some NACDS conferences also cover registration to attend the conferences. Attendance and exhibit fees only pay for attendance and exhibit space at NACDS conferences, and do not vary based on the type or size of the company. The number of companies and the total funding listed in the charts would be dramatically smaller if dues, exhibit fees and all attendance fees were not included. Total sponsorships received by NACDS from all of the companies listed in the enclosed charts constituted less than 4 percent of total revenues received by NACDS since January 2006. Total industry funding (sponsorships, dues and exhibit fees) from these companies constituted less than 17 percent of total NACDS revenues. The figures for 2009 are based on the most recent information available to NACDS. Your letter also asked NACDS to repeat five questions and provide appropriate answers:

1) Please describe the policies for accepting industry funding and whether or not NACDS allows companies to place restrictions or provide guidance on how funding will be spent.

Answer: NACDS accepts industry funding that can be utilized to advance the interests of chain pharmacies. NACDS does not accept restrictions or guidance regarding industry funding received from drug manufacturers, medical device manufacturers, insurance companies or their foundations.

2) If NACDS allows companies to place restrictions on industry funding, then please explain all restrictions and/or guidance for each transfer of value from industry. For every transfer of value with a restriction, please provide the following information: year of transfer, name of company, and restriction placed on funding.

Answer: No restrictions or guidance were accepted from these companies. 3) Please explain what policies, if any that NACDS plans to adopt to ensure transparency of funding in order to provide a greater public trust in the independence of your organization.

Answer: NACDS is a not-for-profit entity that supports appropriate financial transparency. Every year, NACDS discloses a great deal of financial information in detailed tax forms that are made available to the general public. In addition, sponsorships received by NACDS from outside entities are proudly acknowledged on our website and in NACDS conference materials, educational materials and other public statements. From time to time, as necessary, the NACDS Board of Directors considers its transparency measures and considers any need to enhance these policies.

Page 6: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS Letter to Senator Charles Grassley January 27, 2010 Page 3

4) Please explain your policies on disclosure of outside income by your top executives and board members.

Answer: The NACDS Board of Directors has adopted a strict policy designed to disclose potential conflicts of interest. Pursuant to that policy, if outside income of a board member may interfere with or improperly influence the board member’s ability to act in the best interests of NACDS, the board member is obligated to disclose that potential conflict of interest. NACDS has adopted a similar conflict of interest policy for executives and other NACDS employees. Pursuant to that policy, if outside income received by an executive or other employee may influence the individual’s ability to act in the best interests of NACDS or may otherwise create a potential conflict of interest, the employee has a duty to disclose that potential conflict of interest. In particular, executives and other employees are obligated to disclose outside employment or consulting work that may conflict with their jobs at NACDS.

5) Please provide the disclosures of outside income filed with your organizations by your top executives and board members.

Answer: Because no conflicts of interest are known to exist, disclosures of outside income have not been filed with NACDS by our top executives and board members.

NACDS is proud of our record of independently and transparently representing the interests of chain pharmacies. Please let me know if you have any further questions.

Sincerely,

Steven C. Anderson, IOM, CAE President and Chief Executive Officer Enclosure

Page 7: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2006

Rx OTC Company Dues Exhibit Meetings Total

Space Sponsorship Funding

x 3M Pharmaceuticals $9,960.00 $12,450.00 $0.00 $22,410.00

x A&D Medical - LifeSource $2,880.00 $15,220.00 $0.00 $18,100.00

x Abbott - Pharmaceutical Products Division $9,960.00 $44,100.00 $43,500.00 $97,560.00

x Actavis $9,960.00 $39,100.00 $0.00 $49,060.00

x ACTAVIS SouthAtlantic LLC $2,880.00 $0.00 $0.00 $2,880.00

x Alcon Laboratories, Inc. $9,960.00 $27,940.00 $0.00 $37,900.00

x Allergan Inc. $9,960.00 $37,325.00 $0.00 $47,285.00

x Alliant Pharmaceuticals, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Alpharma Pharmaceuticals LLC $1,200.00 $4,300.00 $0.00 $5,500.00

x Amgen Inc. $9,960.00 $4,300.00 $0.00 $14,260.00

x Amneal Pharmaceuticals $2,880.00 $8,950.00 $0.00 $11,830.00

x Amphastar Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Amylin Pharmaceuticals, Inc. $2,880.00 $8,950.00 $0.00 $11,830.00

x Apotex Corp. $8,100.00 $37,250.00 $0.00 $45,350.00

x Apotex Inc. $2,500.00 $0.00 $0.00 $2,500.00

x Apothecary Products, Inc. $8,100.00 $19,500.00 $0.00 $27,600.00

x AR Scientific, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Astellas Pharma US, Inc. $9,960.00 $8,950.00 $0.00 $18,910.00

x AstraZeneca $9,960.00 $65,850.00 $95,000.00 $170,810.00

x Aurobindo Pharma USA, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x AutoMed/An AmerisourceBergen Company $2,880.00 $0.00 $0.00 $2,880.00

x Auxilium Pharmaceuticals, Inc. $4,620.00 $4,300.00 $0.00 $8,920.00

x Axcan Pharma US, Inc. $9,960.00 $8,950.00 $0.00 $18,910.00

x Barr Laboratories, Inc. $9,960.00 $22,450.00 $19,500.00 $51,910.00

x Barrier Therapeutics, Inc. $1,200.00 $0.00 $0.00 $1,200.00

x Bayer HealthCare, Diabetes Care $9,960.00 $55,575.00 $13,500.00 $79,035.00

x Bayer HealthCare, Pharmaceuticals $4,620.00 $0.00 $0.00 $4,620.00

x Berlex Laboratories $9,960.00 $19,500.00 $29,500.00 $58,960.00

x Biovail Pharmaceuticals Inc. $8,100.00 $8,950.00 $0.00 $17,050.00

x Boca Medical Products, Inc. $2,640.00 $10,150.00 $0.00 $12,790.00

x Boehringer Ingelheim Pharmaceuticals, Inc. $9,960.00 $44,650.00 $15,000.00 $69,610.00

x Braintree Laboratories, Inc. $2,880.00 $8,950.00 $0.00 $11,830.00

x Breckenridge Pharmaceutical, Inc. $4,620.00 $8,950.00 $0.00 $13,570.00

x Bristol-Myers Squibb, US Pharmaceutical Group $9,960.00 $44,100.00 $19,500.00 $73,560.00

x Can-Am Care, LLC, An Access Product Marketing Company $4,620.00 $10,000.00 $0.00 $14,620.00

x Caraco Pharmaceutical Laboratories, Ltd. $4,620.00 $13,400.00 $9,500.00 $27,520.00

x Celgene Corporation $9,960.00 $14,300.00 $0.00 $24,260.00

x Centocor Ortho Biotech, LLC $9,960.00 $0.00 $0.00 $9,960.00

x Centocor, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Colgate Oral Pharmaceuticals $9,960.00 $14,300.00 $0.00 $24,260.00

x CollaGenex Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

Page 8: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2006

Rx OTC Company Dues Exhibit Meetings Total

Space Sponsorship Funding

x 3M Pharmaceuticals $9,960.00 $12,450.00 $0.00 $22,410.00

x Columbia Laboratories, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Connetics Corporation $9,960.00 $4,300.00 $0.00 $14,260.00

x CorePharma, LLC $2,310.00 $4,300.00 $0.00 $6,610.00

x Coria Laboratories, Ltd. $2,880.00 $14,450.00 $0.00 $17,330.00

x Cornerstone Therapeutics $2,880.00 $0.00 $0.00 $2,880.00

x Covidien - Mallinckrodt $9,960.00 $51,150.00 $19,500.00 $80,610.00

x Critical Therapeutics $2,880.00 $4,300.00 $9,500.00 $16,680.00

x CV Therapeutics $1,440.00 $4,300.00 $0.00 $5,740.00

x Cypress Pharmaceutical, Inc. $9,960.00 $4,300.00 $0.00 $14,260.00

x Daiichi Sankyo, Inc. $4,620.00 $8,950.00 $0.00 $13,570.00

x Depomed, Inc. $1,680.00 $4,300.00 $0.00 $5,980.00

x Dey, L.P. $9,960.00 $8,950.00 $0.00 $18,910.00

x Dr. Reddy's Laboratories, Inc. $4,620.00 $18,950.00 $0.00 $23,570.00

x Drive Medical Design & Manufacturing $2,880.00 $14,370.00 $0.00 $17,250.00

x Eisai Inc. $8,100.00 $34,500.00 $0.00 $42,600.00

x EMD Serono, Inc. $9,960.00 $14,300.00 $0.00 $24,260.00

x Endo Pharmaceuticals Inc. $9,960.00 $39,100.00 $0.00 $49,060.00

x ETHEX Corporation $9,960.00 $8,950.00 $0.00 $18,910.00

x Eurand Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Falcon Pharmaceuticals, Ltd. $8,100.00 $13,400.00 $0.00 $21,500.00

x Fleming Pharmaceuticals $2,880.00 $0.00 $0.00 $2,880.00

x Forest Pharmaceuticals, Inc. $9,960.00 $23,400.00 $29,500.00 $62,860.00

x Fougera $9,960.00 $46,850.00 $39,500.00 $96,310.00

x G & W Laboratories, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Galderma Laboratories, L.P. $9,960.00 $22,240.00 $0.00 $32,200.00

x Genentech $2,880.00 $0.00 $0.00 $2,880.00

x GENPHARM, L.P. $2,880.00 $14,300.00 $230,000.00 $247,180.00

x Genzyme Corporation $2,880.00 $4,300.00 $0.00 $7,180.00

x Gilead Sciences $4,620.00 $0.00 $0.00 $4,620.00

x Glades Pharmaceuticals, LLC $2,880.00 $8,950.00 $0.00 $11,830.00

x GlaxoSmithKline $9,960.00 $48,750.00 $62,000.00 $120,710.00

x Glenmark Generics Inc., USA $2,880.00 $4,300.00 $0.00 $7,180.00

x Global Pharmaceuticals, a div. of Impax Laboratories, Inc. $4,620.00 $8,950.00 $0.00 $13,570.00

x Greenstone LLC $4,620.00 $13,400.00 $0.00 $18,020.00

x Harris Pharmaceutical, Inc. $960.00 $0.00 $0.00 $960.00

x Heritage Pharmaceuticals Inc. $1,440.00 $4,300.00 $0.00 $5,740.00

x Hi-Tech Pharmacal Co., Inc./Health Care Products Division $2,880.00 $8,950.00 $0.00 $11,830.00

x Home Diagnostics, Inc. $4,620.00 $39,650.00 $0.00 $44,270.00

x IVAX Laboratories $4,620.00 $0.00 $0.00 $4,620.00

x Johnson & Johnson Healthcare Products $9,960.00 $80,650.00 $0.00 $90,610.00

Page 9: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2006

Rx OTC Company Dues Exhibit Meetings Total

Space Sponsorship Funding

x 3M Pharmaceuticals $9,960.00 $12,450.00 $0.00 $22,410.00

x King Pharmaceuticals $9,960.00 $4,300.00 $0.00 $14,260.00

x Kowa Pharmaceuticals America, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Lannett Company, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Lifeclinic International, Inc. $2,880.00 $12,050.00 $0.00 $14,930.00

x LifeScan, Inc. A Johnson & Johnson Company $9,960.00 $23,950.00 $0.00 $33,910.00

x Lilly USA, LLC $9,960.00 $58,100.00 $39,500.00 $107,560.00

x Lupin Pharmaceuticals, Inc. $2,880.00 $18,950.00 $0.00 $21,830.00

x Meda Pharmaceuticals Inc. $9,960.00 $4,300.00 $0.00 $14,260.00

x Medicis Pharmaceutical Corporation $8,100.00 $4,300.00 $0.00 $12,400.00

x MedImmune, LLC $2,880.00 $4,300.00 $0.00 $7,180.00

x Merck & Co., Inc. $9,960.00 $18,950.00 $40,000.00 $68,910.00

x Merz Pharmaceuticals, LLC $4,620.00 $11,425.00 $495.00 $16,540.00

x Microlife USA, Inc. $2,880.00 $29,870.00 $0.00 $32,750.00

x MiddleBrook Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Midlothian Laboratories, a division of Hi-Tech Pharmacal $2,880.00 $4,300.00 $0.00 $7,180.00

x Morton Grove Pharmaceuticals, Inc. $4,620.00 $8,950.00 $9,500.00 $23,070.00

x MTS Medication Technologies $1,920.00 $19,500.00 $0.00 $21,420.00

x Mylan Pharmaceuticals $9,960.00 $48,750.00 $29,500.00 $88,210.00

x Nephron Pharmaceuticals Corporation $960.00 $0.00 $0.00 $960.00

x Nnodum Pharmaceuticals $1,680.00 $4,300.00 $0.00 $5,980.00

x Novo Nordisk Inc. $9,960.00 $23,400.00 $9,500.00 $42,860.00

x Omron Healthcare Inc. $9,960.00 $43,250.00 $10,000.00 $63,210.00

x Organon USA Inc. $9,960.00 $12,050.00 $0.00 $22,010.00

x Ortho-McNeil-Janssen Pharmaceuticals, Inc. $9,960.00 $29,500.00 $9,500.00 $48,960.00

x Otsuka America Pharmaceutical, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Paddock Laboratories, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Par Pharmaceutical, Inc. $9,960.00 $39,100.00 $10,000.00 $59,060.00

x ParMed Pharmaceuticals $960.00 $4,300.00 $0.00 $5,260.00

x Patriot Pharmaceuticals LLC $2,880.00 $4,300.00 $0.00 $7,180.00

x Perrigo Company $9,960.00 $61,110.00 $20,000.00 $91,070.00

x Perrigo Pharmaceuticals Company $9,960.00 $38,750.00 $0.00 $48,710.00

x Pfizer Inc, Worldwide Pharmaceuticals $9,960.00 $39,100.00 $60,000.00 $109,060.00

x Pharmaceutical Associates, Inc. $2,880.00 $8,950.00 $0.00 $11,830.00

x Pharmacy Automation Supplies $1,440.00 $0.00 $0.00 $1,440.00

x Philips Respironics, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x PLIVA $8,100.00 $18,950.00 $10,000.00 $37,050.00

x Procter & Gamble Health Care Products $9,960.00 $0.00 $0.00 $9,960.00

x Purdue Pharma L.P. $9,960.00 $19,100.00 $0.00 $29,060.00

x Ranbaxy Inc. $9,960.00 $23,400.00 $0.00 $33,360.00

x Reliant Pharmaceuticals Inc. $8,100.00 $4,300.00 $0.00 $12,400.00

Page 10: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2006

Rx OTC Company Dues Exhibit Meetings Total

Space Sponsorship Funding

x 3M Pharmaceuticals $9,960.00 $12,450.00 $0.00 $22,410.00

x Rising Pharmaceuticals, Inc. $4,620.00 $8,950.00 $0.00 $13,570.00

x River's Edge Pharmaceuticals, LLC $2,880.00 $4,300.00 $0.00 $7,180.00

x Roche Diagnostics $9,960.00 $23,500.00 $0.00 $33,460.00

x Roche Laboratories, Inc. $9,960.00 $18,950.00 $34,500.00 $63,410.00

x Roxane Laboratories (A Boehringer Ingelheim Co.) $4,620.00 $8,950.00 $0.00 $13,570.00

x S4 Consulting $1,440.00 $0.00 $0.00 $1,440.00

x Salix Pharmaceuticals, Inc. $8,100.00 $29,500.00 $0.00 $37,600.00

x sanofi-aventis $9,960.00 $37,250.00 $33,500.00 $80,710.00

x Schering-Plough $9,960.00 $29,500.00 $54,500.00 $93,960.00

x Schwarz Pharma, Inc. $8,100.00 $29,500.00 $29,500.00 $67,100.00

x Sciele Pharma, Inc $9,960.00 $4,300.00 $0.00 $14,260.00

x Sepracor Inc. $5,340.00 $14,300.00 $0.00 $19,640.00

x Shire US Inc. $9,960.00 $4,300.00 $0.00 $14,260.00

x SkinMedica, Inc. $4,620.00 $4,300.00 $0.00 $8,920.00

x Solvay Pharmaceuticals, Inc. $9,960.00 $4,300.00 $0.00 $14,260.00

x STADA Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Stiefel, a GSK Company $2,880.00 $14,795.00 $0.00 $17,675.00

x Takeda Pharmaceuticals North America, Inc. $9,960.00 $27,250.00 $9,500.00 $46,710.00

x TAP Pharmaceuticals Inc. $9,960.00 $8,950.00 $0.00 $18,910.00

x Taro Pharmaceuticals U.S.A., Inc. $9,960.00 $63,250.00 $19,500.00 $92,710.00

x Teva Pharmaceuticals $9,960.00 $62,350.00 $19,500.00 $91,810.00

x Ther-Rx Corporation $9,960.00 $4,300.00 $0.00 $14,260.00

x Triax Pharmaceuticals $1,440.00 $4,300.00 $0.00 $5,740.00

x UCB, Inc. $2,760.00 $4,300.00 $0.00 $7,060.00

x Upsher-Smith Laboratories, Inc. $9,960.00 $35,500.00 $9,500.00 $54,960.00

x URL Pharma $9,960.00 $18,950.00 $29,500.00 $58,410.00

x Valeant Pharmaceuticals North America $2,880.00 $8,950.00 $0.00 $11,830.00

x VaxServe $4,620.00 $8,950.00 $0.00 $13,570.00

x Victory Pharma, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Vintage Pharmaceuticals, LLC $2,880.00 $0.00 $0.00 $2,880.00

x Vision Pharma LLC $2,880.00 $4,300.00 $0.00 $7,180.00

x Warner Chilcott $9,960.00 $4,300.00 $0.00 $14,260.00

x Watson Pharma, Inc. $9,960.00 $57,185.00 $0.00 $67,145.00

x West-ward Pharmaceutical Corp. $4,620.00 $4,300.00 $0.00 $8,920.00

x Wockhardt USA, Inc./Morton Grove Pharmaceuticals $2,880.00 $4,300.00 $0.00 $7,180.00

x Wyeth Pharmaceuticals $9,960.00 $39,100.00 $110,000.00 $159,060.00

x Xanodyne Pharmaceutical, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Zydus Pharmaceuticals (USA) Inc. $2,880.00 $0.00 $0.00 $2,880.00

Subtotal - Rx Companies $970,690.00 $2,490,655.00 $1,232,495.00 $4,693,840.00

Page 11: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2006

Rx OTC Company Dues Exhibit Meetings Total

Space Sponsorship Funding

x 3M Pharmaceuticals $9,960.00 $12,450.00 $0.00 $22,410.00

x Abbott Medical Optics, Inc. $9,960.00 $32,600.00 $0.00 $42,560.00

x Advanced Vision Research $2,880.00 $0.00 $0.00 $2,880.00

x ALVA-AMCO Pharmacal Cos., Inc. $2,880.00 $10,150.00 $495.00 $13,525.00

x Amerifit Brands $9,960.00 $100.00 $0.00 $10,060.00

x Ansell Healthcare Products LLC $4,620.00 $14,865.00 $0.00 $19,485.00

x B.F. Ascher & Company, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Bayer HealthCare, Consumer Care $9,960.00 $15,000.00 $70,000.00 $94,960.00

x BD Diabetes Care $9,960.00 $29,100.00 $10,000.00 $49,060.00

x Boehringer Ingelheim Consumer Health Care $8,100.00 $31,470.00 $0.00 $39,570.00

x Cadbury North America $9,960.00 $14,350.00 $19,500.00 $43,810.00

x Chattem, Inc. $9,960.00 $32,600.00 $0.00 $42,560.00

x CIBA Vision Corporation $9,960.00 $0.00 $10,000.00 $19,960.00

x Combe Incorporated $9,960.00 $15,200.00 $0.00 $25,160.00

x Fleet Laboratories $9,960.00 $11,000.00 $0.00 $20,960.00

x Health Enterprises, Inc. $2,880.00 $6,000.00 $995.00 $9,875.00

x Hisamitsu America, Inc. $2,880.00 $6,800.00 $0.00 $9,680.00

x J. R. Watkins, Incorporated $2,880.00 $4,510.00 $0.00 $7,390.00

x Kobayashi Healthcare, LLC $2,880.00 $0.00 $0.00 $2,880.00

x Lil' Drug Store Products, Inc. $4,620.00 $9,645.00 $0.00 $14,265.00

x Majestic Drug Co., Inc. $2,880.00 $4,725.00 $1,490.00 $9,095.00

x Merix Pharmaceutical Corp. $2,880.00 $11,425.00 $0.00 $14,305.00

x Mission Pharmacal Co. $8,100.00 $9,645.00 $0.00 $17,745.00

x Navajo Manufacturing Co. $8,100.00 $15,200.00 $0.00 $23,300.00

x OHM Laboratories, Inc. $8,100.00 $10,150.00 $0.00 $18,250.00

x Pfizer Consumer Healthcare $9,960.00 $77,475.00 $35,000.00 $122,435.00

x Prestige Brands, Inc., Medtech Products Division $8,100.00 $0.00 $0.00 $8,100.00

Procter & Gamble Company $9,960.00 $138,550.00 $30,000.00 $178,510.00

x Procter & Gamble Beauty Care Products $9,960.00 $0.00 $0.00 $9,960.00

x Ricola USA, Inc. $8,100.00 $31,590.00 $495.00 $40,185.00

x Schering-Plough Consumer Health Care $9,960.00 $71,800.00 $36,000.00 $117,760.00

x Similasan Corporation $4,620.00 $10,000.00 $0.00 $14,620.00

x Tec Laboratories, Inc. $2,880.00 $14,400.00 $0.00 $17,280.00

x Tender Corporation $2,880.00 $4,510.00 $0.00 $7,390.00

x The Mentholatum Company $9,960.00 $31,470.00 $0.00 $41,430.00

x The Triad Group, Inc. $2,880.00 $10,150.00 $0.00 $13,030.00

x TriDerma MD® $2,880.00 $4,300.00 $0.00 $7,180.00

x W.F. Young, Inc. $2,880.00 $5,150.00 $0.00 $8,030.00

Subtotal-OTC companies $242,220.00 $683,930.00 $213,975.00 $1,140,125.00

Total $1,212,910.00 $3,174,585.00 $1,446,470.00 $5,833,965.00

Page 12: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2007

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x A&D Medical - LifeSource $2,880.00 $15,645.00 $0.00 $18,525.00

x Abbott - Pharmaceutical Products Division $9,960.00 $40,700.00 $21,000.00 $71,660.00

x Actavis $9,960.00 $40,700.00 $0.00 $50,660.00

x Alcon Laboratories, Inc. $9,960.00 $27,940.00 $0.00 $37,900.00

x Allergan Inc. $9,960.00 $36,820.00 $500.00 $47,280.00

x Alliant Pharmaceuticals, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x Alpharma Pharmaceuticals LLC $9,960.00 $4,500.00 $0.00 $14,460.00

x Amgen Inc. $9,960.00 $100.00 $0.00 $10,060.00

x Amneal Pharmaceuticals $2,880.00 $9,400.00 $0.00 $12,280.00

x Amphastar Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Amylin Pharmaceuticals, Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x Anchen Pharmaceuticals, Inc. $2,400.00 $0.00 $0.00 $2,400.00

x Apotex Corp. $8,100.00 $38,700.00 $19,500.00 $66,300.00

x Apothecary Products, Inc. $8,100.00 $0.00 $0.00 $8,100.00

x AR Scientific, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Astellas Pharma US, Inc. $9,960.00 $30,500.00 $10,000.00 $50,460.00

x AstraZeneca $9,960.00 $63,600.00 $75,000.00 $148,560.00

x Aurobindo Pharma USA, Inc. $4,620.00 $14,500.00 $0.00 $19,120.00

x Auxilium Pharmaceuticals, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Axcan Pharma US, Inc. $9,960.00 $9,400.00 $0.00 $19,360.00

x Barr Laboratories, Inc. $9,960.00 $29,900.00 $19,500.00 $59,360.00

x Barrier Therapeutics, Inc. $2,880.00 $8,000.00 $0.00 $10,880.00

x Bayer HealthCare, Diabetes Care $9,960.00 $80,300.00 $995.00 $91,255.00

x Bayer HealthCare, Pharmaceuticals $4,620.00 $20,500.00 $10,000.00 $35,120.00

x Berlex Laboratories $9,960.00 $0.00 $9,500.00 $19,460.00

x Biovail Pharmaceuticals Inc. $4,620.00 $0.00 $0.00 $4,620.00

x Boca Medical Products, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Boehringer Ingelheim Pharmaceuticals, Inc. $9,960.00 $81,000.00 $10,000.00 $100,960.00

x Braintree Laboratories, Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x Breckenridge Pharmaceutical, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x Bristol-Myers Squibb, US Pharmaceutical Group $9,960.00 $40,700.00 $19,500.00 $70,160.00

x Cadista Pharmaceuticals Inc. $1,680.00 $12,700.00 $0.00 $14,380.00

x Can-Am Care, LLC, An Access Product Marketing Company $4,620.00 $20,350.00 $0.00 $24,970.00

x Caraco Pharmaceutical Laboratories, Ltd. $4,620.00 $13,400.00 $25,000.00 $43,020.00

x Celgene Corporation $9,960.00 $4,500.00 $0.00 $14,460.00

x Centocor Ortho Biotech, LLC $9,960.00 $0.00 $0.00 $9,960.00

x Centocor, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Colgate Oral Pharmaceuticals $9,960.00 $4,500.00 $0.00 $14,460.00

x CollaGenex Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Columbia Laboratories, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x CorePharma, LLC $2,880.00 $4,500.00 $0.00 $7,380.00

Page 13: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2007

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x Coria Laboratories, Ltd. $8,100.00 $8,800.00 $0.00 $16,900.00

x Cornerstone Therapeutics $2,880.00 $4,500.00 $0.00 $7,380.00

x Covidien - Mallinckrodt $9,960.00 $57,400.00 $10,000.00 $77,360.00

x Critical Therapeutics $2,880.00 $4,500.00 $9,500.00 $16,880.00

x CV Therapeutics $2,880.00 $4,500.00 $0.00 $7,380.00

x Cypress Pharmaceutical, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Daiichi Sankyo, Inc. $9,960.00 $9,400.00 $0.00 $19,360.00

x Depomed, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Dr. Reddy's Laboratories, Inc. $8,100.00 $23,700.00 $0.00 $31,800.00

x Drive Medical Design & Manufacturing $2,880.00 $0.00 $0.00 $2,880.00

x Eisai Inc. $9,960.00 $30,500.00 $0.00 $40,460.00

x EMD Serono, Inc. $9,960.00 $14,500.00 $0.00 $24,460.00

x Endo Pharmaceuticals Inc. $9,960.00 $40,700.00 $0.00 $50,660.00

x ETHEX Corporation $9,960.00 $20,500.00 $0.00 $30,460.00

x Eurand Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Falcon Pharmaceuticals, Ltd. $8,100.00 $14,100.00 $0.00 $22,200.00

x Fleming Pharmaceuticals $4,620.00 $0.00 $0.00 $4,620.00

x Forest Pharmaceuticals, Inc. $9,960.00 $24,100.00 $29,500.00 $63,560.00

x Fougera $8,100.00 $46,850.00 $39,500.00 $94,450.00

x G & W Laboratories, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Galderma Laboratories, L.P. $9,960.00 $23,840.00 $0.00 $33,800.00

x Genentech $2,880.00 $0.00 $0.00 $2,880.00

x GENPHARM, L.P. $4,620.00 $9,400.00 $9,500.00 $23,520.00

x Genzyme Corporation $2,880.00 $4,500.00 $0.00 $7,380.00

x Gilead Sciences $9,960.00 $0.00 $0.00 $9,960.00

x Glades Pharmaceuticals, LLC $4,620.00 $8,950.00 $0.00 $13,570.00

x GlaxoSmithKline $9,960.00 $50,800.00 $72,000.00 $132,760.00

x Glenmark Generics Inc., USA $2,880.00 $4,500.00 $0.00 $7,380.00

x Global Pharmaceuticals, a div. of Impax Laboratories, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Graceway Pharmaceuticals, LLC $4,150.00 $4,500.00 $0.00 $8,650.00

x Greenstone LLC $4,620.00 $14,100.00 $0.00 $18,720.00

x Harris Pharmaceutical, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Heritage Pharmaceuticals Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x Hi-Tech Pharmacal Co., Inc./Health Care Products Division $2,880.00 $9,400.00 $0.00 $12,280.00

x Home Diagnostics, Inc. $4,620.00 $40,650.00 $0.00 $45,270.00

x Inspire $2,160.00 $4,500.00 $0.00 $6,660.00

x Intendis, Inc. $3,375.00 $0.00 $0.00 $3,375.00

x Interpharm, Inc $2,880.00 $4,500.00 $0.00 $7,380.00

x Johnson & Johnson Healthcare Products $9,960.00 $156,100.00 $0.00 $166,060.00

x King Pharmaceuticals $9,960.00 $4,500.00 $0.00 $14,460.00

x Kowa Pharmaceuticals America, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

Page 14: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2007

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x KVK-TECH, INC. $1,680.00 $4,500.00 $0.00 $6,180.00

x Lannett Company, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Lifeclinic International, Inc. $2,880.00 $12,700.00 $0.00 $15,580.00

x LifeScan, Inc. A Johnson & Johnson Company $9,960.00 $24,400.00 $0.00 $34,360.00

x Lilly USA, LLC $9,960.00 $55,400.00 $83,500.00 $148,860.00

x Lupin Pharmaceuticals, Inc. $4,620.00 $26,700.00 $13,500.00 $44,820.00

x Medicis Pharmaceutical Corporation $8,100.00 $4,500.00 $0.00 $12,600.00

x Merck & Co., Inc. $9,960.00 $30,500.00 $50,000.00 $90,460.00

x Merz Pharmaceuticals, LLC $4,620.00 $15,075.00 $495.00 $20,190.00

x Microlife USA, Inc. $4,620.00 $4,300.00 $0.00 $8,920.00

x MiddleBrook Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Midlothian Laboratories, a division of Hi-Tech Pharmacal $2,880.00 $4,300.00 $0.00 $7,180.00

x Morton Grove Pharmaceuticals, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x Mylan Pharmaceuticals $9,960.00 $50,800.00 $10,000.00 $70,760.00

x NeilMED Pharmaceuticals, Inc. $1,440.00 $5,025.00 $0.00 $6,465.00

x Nephron Pharmaceuticals Corporation $2,880.00 $4,500.00 $1,500.00 $8,880.00

x NextWave Pharmaceuticals - OTC Division $1,440.00 $4,300.00 $1,000.00 $6,740.00

x Nnodum Pharmaceuticals $2,880.00 $4,300.00 $0.00 $7,180.00

x Novartis Consumer Health, Inc. (OTC N.A.) $9,960.00 $81,325.00 $15,495.00 $106,780.00

x Novartis Pharmaceuticals Corporation $9,960.00 $32,600.00 $45,000.00 $87,560.00

x Novartis Vaccines $1,680.00 $4,500.00 $5,000.00 $11,180.00

x Novo Nordisk Inc. $8,100.00 $30,500.00 $19,500.00 $58,100.00

x Omron Healthcare Inc. $9,960.00 $25,200.00 $0.00 $35,160.00

x Ortho-McNeil-Janssen Pharmaceuticals, Inc. $9,960.00 $30,500.00 $0.00 $40,460.00

x Otsuka America Pharmaceutical, Inc. $2,880.00 $0.00 $10,000.00 $12,880.00

x Paddock Laboratories, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x ParMed Pharmaceuticals $2,880.00 $4,500.00 $0.00 $7,380.00

x Patriot Pharmaceuticals LLC $4,620.00 $4,500.00 $0.00 $9,120.00

x Perrigo Company $9,960.00 $57,710.00 $20,000.00 $87,670.00

x Perrigo Pharmaceuticals Company $9,960.00 $17,600.00 $0.00 $27,560.00

x Pfizer Inc, Worldwide Pharmaceuticals $9,960.00 $35,500.00 $61,000.00 $106,460.00

x Pharmaceutical Associates, Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x PharmaSmart International $2,880.00 $4,500.00 $0.00 $7,380.00

x Philips Respironics, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Pinellas Pharmaceuticals, Inc. $1,440.00 $4,500.00 $0.00 $5,940.00

x Procter & Gamble Health Care Products $9,960.00 $0.00 $0.00 $9,960.00

x Purdue Pharma L.P. $9,960.00 $19,550.00 $10,495.00 $40,005.00

x Ranbaxy Inc. $9,960.00 $19,400.00 $20,000.00 $49,360.00

x Reliant Pharmaceuticals Inc. $8,100.00 $4,500.00 $0.00 $12,600.00

x Rising Pharmaceuticals, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x River's Edge Pharmaceuticals, LLC $2,880.00 $4,300.00 $0.00 $7,180.00

Page 15: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2007

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x Roche Diagnostics $9,960.00 $24,100.00 $0.00 $34,060.00

x Roche Laboratories, Inc. $9,960.00 $24,100.00 $38,500.00 $72,560.00

x Roxane Laboratories (A Boehringer Ingelheim Co.) $9,960.00 $8,950.00 $0.00 $18,910.00

x Salix Pharmaceuticals, Inc. $9,960.00 $30,500.00 $0.00 $40,460.00

x Sandoz $9,960.00 $63,600.00 $78,500.00 $152,060.00

x Sandoz Canada $2,500.00 $0.00 $5,000.00 $7,500.00

x sanofi-aventis $9,960.00 $38,700.00 $35,000.00 $83,660.00

x Schering-Plough $9,960.00 $43,700.00 $9,500.00 $63,160.00

x Schwarz Pharma, Inc. $9,960.00 $10,000.00 $19,500.00 $39,460.00

x Sciele Pharma, Inc $9,960.00 $4,500.00 $0.00 $14,460.00

x Security Equipment Corporation $1,200.00 $0.00 $0.00 $1,200.00

x Sepracor Inc. $9,960.00 $14,500.00 $0.00 $24,460.00

x Shire US Inc. $9,960.00 $17,600.00 $0.00 $27,560.00

x SkinMedica, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Solvay Pharmaceuticals, Inc. $9,960.00 $4,500.00 $0.00 $14,460.00

x Stiefel, a GSK Company $9,960.00 $14,370.00 $0.00 $24,330.00

x Takeda Pharmaceuticals North America, Inc. $9,960.00 $30,700.00 $9,500.00 $50,160.00

x TAP Pharmaceuticals Inc. $9,960.00 $9,400.00 $0.00 $19,360.00

x Taro Pharmaceuticals U.S.A., Inc. $8,100.00 $29,550.00 $0.00 $37,650.00

x Teva Pharmaceuticals $9,960.00 $64,400.00 $19,500.00 $93,860.00

x Ther-Rx Corporation $4,620.00 $4,500.00 $0.00 $9,120.00

x Torrent Pharma Inc. $1,920.00 $4,500.00 $0.00 $6,420.00

x Triax Pharmaceuticals $2,880.00 $0.00 $0.00 $2,880.00

x UCB, Inc. $9,960.00 $20,500.00 $15,000.00 $45,460.00

x Upsher-Smith Laboratories, Inc. $9,960.00 $34,000.00 $23,500.00 $67,460.00

x URL Pharma $9,960.00 $19,400.00 $29,500.00 $58,860.00

x Valeant Pharmaceuticals North America $2,880.00 $0.00 $0.00 $2,880.00

x VaxServe $4,620.00 $9,400.00 $0.00 $14,020.00

x Victory Pharma, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Vision Pharma LLC $2,880.00 $4,500.00 $0.00 $7,380.00

x Warner Chilcott $9,960.00 $4,500.00 $0.00 $14,460.00

x Watson Pharma, Inc. $9,960.00 $59,485.00 $0.00 $69,445.00

x West-ward Pharmaceutical Corp. $4,620.00 $4,500.00 $0.00 $9,120.00

x Wockhardt USA, Inc./Morton Grove Pharmaceuticals $2,880.00 $4,500.00 $0.00 $7,380.00

x Wyeth Pharmaceuticals $9,960.00 $60,900.00 $65,000.00 $135,860.00

x Xanodyne Pharmaceutical, Inc. $9,960.00 $0.00 $0.00 $9,960.00

x Zydus Pharmaceuticals (USA) Inc. $2,880.00 $20,500.00 $0.00 $23,380.00

Subtotal - Rx Companies $1,016,885.00 $2,747,285.00 $1,104,980.00 $4,869,150.00

X Abbott Diabetes Care $9,960.00 $29,550.00 $0.00 $39,510.00

X Abbott Medical Optics, Inc. $9,960.00 $31,470.00 $0.00 $41,430.00

Page 16: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2007

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

X Advanced Vision Research $2,880.00 $0.00 $0.00 $2,880.00

X Alaven Pharmaceutical LLC $1,440.00 $4,500.00 $1,000.00 $6,940.00

X ALVA-AMCO Pharmacal Cos., Inc. $2,880.00 $9,645.00 $495.00 $13,020.00

X Amerifit Brands $9,960.00 $15,715.00 $0.00 $25,675.00

X Ansell Healthcare Products LLC $4,620.00 $14,865.00 $0.00 $19,485.00

X B.F. Ascher & Company, Inc. $2,880.00 $0.00 $0.00 $2,880.00

X Bayer HealthCare, Consumer Care $9,960.00 $16,275.00 $43,500.00 $69,735.00

X BD Diabetes Care $9,960.00 $29,550.00 $0.00 $39,510.00

X Boehringer Ingelheim Consumer Health Care $8,100.00 $31,895.00 $0.00 $39,995.00

X Cadbury North America $9,960.00 $24,925.00 $0.00 $34,885.00

X Chattem, Inc. $9,960.00 $32,600.00 $50.00 $42,610.00

X CIBA Vision Corporation $9,960.00 $0.00 $10,000.00 $19,960.00

X Combe Incorporated $9,960.00 $15,200.00 $0.00 $25,160.00

X Fleet Laboratories $9,960.00 $10,495.00 $0.00 $20,455.00

X Health Enterprises, Inc. $2,880.00 $5,785.00 $995.00 $9,660.00

X Hisamitsu America, Inc. $2,880.00 $4,085.00 $0.00 $6,965.00

X Kobayashi Healthcare, LLC $2,880.00 $0.00 $0.00 $2,880.00

X Lil' Drug Store Products, Inc. $4,620.00 $5,150.00 $0.00 $9,770.00

X Majestic Drug Co., Inc. $2,880.00 $4,510.00 $1,540.00 $8,930.00

X Merix Pharmaceutical Corp. $2,880.00 $11,000.00 $0.00 $13,880.00

X Mission Pharmacal Co. $8,100.00 $9,645.00 $0.00 $17,745.00

X Navajo Manufacturing Co. $2,880.00 $16,050.00 $0.00 $18,930.00

X OHM Laboratories, Inc. $4,620.00 $10,150.00 $0.00 $14,770.00

X Pfizer Consumer Healthcare $0.00 $6,900.00 $0.00 $6,900.00

X Prestige Brands, Inc., Medtech Products Division $9,960.00 $5,150.00 $0.00 $15,110.00

Procter & Gamble Company $9,960.00 $95,300.00 $39,500.00 $144,760.00

X Procter & Gamble Beauty Care Products $9,960.00 $0.00 $0.00 $9,960.00

X Ricola USA, Inc. $8,100.00 $31,590.00 $495.00 $40,185.00

X Schering-Plough Consumer Health Care $9,960.00 $71,800.00 $26,000.00 $107,760.00

X Similasan Corporation $4,620.00 $0.00 $0.00 $4,620.00

X Tec Laboratories, Inc. $2,880.00 $4,085.00 $0.00 $6,965.00

X Tender Corporation $2,880.00 $4,725.00 $0.00 $7,605.00

X The Mentholatum Company $9,960.00 $32,600.00 $0.00 $42,560.00

X The Triad Group, Inc. $2,880.00 $10,575.00 $0.00 $13,455.00

X TriDerma MD® $2,880.00 $0.00 $0.00 $2,880.00

X W.F. Young, Inc. $2,880.00 $5,150.00 $0.00 $8,030.00

Subtotal - OTC Companies $233,940.00 $600,935.00 $123,575.00 $958,450.00

TOTAL $1,250,825.00 $3,348,220.00 $1,228,555.00 $5,827,600.00

Page 17: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2008

RX OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x A&D Medical - LifeSource $2,880.00 $14,650.00 $0.00 $17,530.00

x Abbott - Pharmaceutical Products Division $9,960.00 $45,700.00 $41,600.00 $97,260.00

x Abbott Diabetes Care $9,960.00 $19,400.00 $0.00 $29,360.00

x Accera, Inc. $1,920.00 $4,500.00 $0.00 $6,420.00

x Actavis $9,960.00 $40,700.00 $0.00 $50,660.00

x Alcon Laboratories, Inc. $9,960.00 $28,700.00 $0.00 $38,660.00

x Allergan Inc. $9,960.00 $37,950.00 $0.00 $47,910.00

x Alpharma Pharmaceuticals LLC $9,960.00 $4,500.00 $200.00 $14,660.00

x Amerigen Pharmaceuticals, Inc. $2,880.00 $2,350.00 $0.00 $5,230.00

x Amgen Inc. $9,960.00 $12,700.00 $0.00 $22,660.00

x Amneal Pharmaceuticals $4,620.00 $14,100.00 $9,500.00 $28,220.00

x Amphastar Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Amylin Pharmaceuticals, Inc. $9,960.00 $9,400.00 $0.00 $19,360.00

x Anchen Pharmaceuticals, Inc. $2,880.00 $0.00 $200.00 $3,080.00

x Apotex Corp. $8,100.00 $39,000.00 $50,200.00 $97,300.00

x Apothecary Products, Inc. $8,100.00 $10,150.00 $0.00 $18,250.00

x AR Scientific, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x ARKRAY USA, Inc. $2,160.00 $4,300.00 $995.00 $7,455.00

x Ascend Therapeutics, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Astellas Pharma US, Inc. $9,960.00 $30,500.00 $0.00 $40,460.00

x AstraZeneca $9,960.00 $68,900.00 $75,000.00 $153,860.00

x Aurobindo Pharma USA, Inc. $8,100.00 $19,400.00 $0.00 $27,500.00

x Auxilium Pharmaceuticals, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Axcan Pharma US, Inc. $9,960.00 $9,400.00 $4,000.00 $23,360.00

x Barr Laboratories, Inc. $9,960.00 $31,400.00 $25,000.00 $66,360.00

x Barrier Therapeutics, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Bayer HealthCare, Diabetes Care $9,960.00 $22,325.00 $0.00 $32,285.00

x Bayer HealthCare, Pharmaceuticals $4,620.00 $40,800.00 $0.00 $45,420.00

x Biovail Pharmaceuticals Inc. $4,620.00 $0.00 $0.00 $4,620.00

x Boca Medical Products, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Boehringer Ingelheim Pharmaceuticals, Inc. $9,960.00 $46,900.00 $34,500.00 $91,360.00

x Braintree Laboratories, Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x Breckenridge Pharmaceutical, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x Bristol-Myers Squibb, US Pharmaceutical Group $9,960.00 $40,700.00 $34,500.00 $85,160.00

x Brookstone Pharmaceuticals, LLC $1,200.00 $4,500.00 $0.00 $5,700.00

Page 18: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2008

x Cadista Pharmaceuticals Inc. $2,880.00 $12,700.00 $0.00 $15,580.00

x Can-Am Care, LLC, An Access Product Marketing Company $4,620.00 $20,150.00 $0.00 $24,770.00

x Caraco Pharmaceutical Laboratories, Ltd. $0.00 $14,100.00 $25,000.00 $39,100.00

x Celgene Corporation $9,960.00 $4,500.00 $0.00 $14,460.00

x Centocor Ortho Biotech, LLC $9,960.00 $0.00 $0.00 $9,960.00

x Colgate Oral Pharmaceuticals $4,620.00 $4,500.00 $0.00 $9,120.00

x CollaGenex Pharmaceuticals, Inc. $4,620.00 $0.00 $0.00 $4,620.00

x Columbia Laboratories, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x CorePharma, LLC $2,880.00 $4,500.00 $0.00 $7,380.00

x Coria Laboratories, Ltd. $8,100.00 $8,800.00 $0.00 $16,900.00

x Cornerstone Therapeutics $2,880.00 $4,500.00 $0.00 $7,380.00

x Covidien - Mallinckrodt $9,960.00 $64,800.00 $19,700.00 $94,460.00

x Critical Therapeutics $2,880.00 $0.00 $9,500.00 $12,380.00

x CV Therapeutics $8,100.00 $4,500.00 $0.00 $12,600.00

x Cypress Pharmaceutical, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Daiichi Sankyo, Inc. $9,960.00 $4,500.00 $0.00 $14,460.00

x Depomed, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Dr. Reddy's Laboratories, Inc. $8,100.00 $29,550.00 $0.00 $37,650.00

x Drive Medical Design & Manufacturing $2,880.00 $0.00 $1,500.00 $4,380.00

x Eisai Inc. $9,960.00 $30,500.00 $0.00 $40,460.00

x EMD Serono, Inc. $9,960.00 $4,500.00 $0.00 $14,460.00

x Endo Pharmaceuticals Inc. $9,960.00 $30,700.00 $0.00 $40,660.00

x ETHEX Corporation $9,960.00 $30,500.00 $200.00 $40,660.00

x Eurand Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Falcon Pharmaceuticals, Ltd. $8,100.00 $14,100.00 $0.00 $22,200.00

x Fleming Pharmaceuticals $4,620.00 $0.00 $0.00 $4,620.00

x Forest Pharmaceuticals, Inc. $9,960.00 $24,100.00 $29,500.00 $63,560.00

x Fougera $9,960.00 $48,900.00 $34,500.00 $93,360.00

x G & W Laboratories, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Galderma Laboratories, L.P. $9,960.00 $25,025.00 $0.00 $34,985.00

x Genentech $2,880.00 $0.00 $0.00 $2,880.00

x Genzyme Corporation $2,880.00 $4,500.00 $0.00 $7,380.00

x Gilead Sciences $9,960.00 $0.00 $0.00 $9,960.00

x Glades Pharmaceuticals, LLC $4,620.00 $9,400.00 $0.00 $14,020.00

x GlaxoSmithKline $9,960.00 $50,800.00 $28,500.00 $89,260.00

x Glenmark Generics Inc., USA $2,880.00 $9,400.00 $0.00 $12,280.00

x Global Pharmaceuticals, a div. of Impax Laboratories, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

Page 19: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2008

x Graceway Pharmaceuticals, LLC $9,960.00 $4,500.00 $0.00 $14,460.00

x Greenstone LLC $4,620.00 $29,100.00 $0.00 $33,720.00

x Harris Pharmaceutical, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Heritage Pharmaceuticals Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x Hi-Tech Pharmacal Co., Inc./Health Care Products Division $2,880.00 $9,400.00 $0.00 $12,280.00

x Home Diagnostics, Inc. $4,620.00 $41,075.00 $0.00 $45,695.00

x Inspire $2,880.00 $4,500.00 $0.00 $7,380.00

x Intendis, Inc. $8,100.00 $0.00 $0.00 $8,100.00

x Interpharm, Inc $0.00 $4,500.00 $0.00 $4,500.00

x Janssen Pharmaceutica Products, L.P. $0.00 $0.00 $165,000.00 $165,000.00

x Johnson & Johnson Healthcare Products $9,960.00 $121,100.00 $0.00 $131,060.00

x King Pharmaceuticals $9,960.00 $4,500.00 $0.00 $14,460.00

x Kowa Pharmaceuticals America, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x Kremers Urban LLC $8,100.00 $30,500.00 $0.00 $38,600.00

x KVK-TECH, INC. $2,880.00 $4,500.00 $0.00 $7,380.00

x Lannett Company, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Lifeclinic International, Inc. $2,880.00 $40,500.00 $15,000.00 $58,380.00

x LifeScan, Inc. A Johnson & Johnson Company $9,960.00 $24,400.00 $0.00 $34,360.00

x Lilly USA, LLC $9,960.00 $60,400.00 $94,450.00 $164,810.00

x Lupin Pharmaceuticals, Inc. $4,620.00 $27,900.00 $13,500.00 $46,020.00

x Meda Pharmaceuticals Inc. $9,960.00 $4,500.00 $0.00 $14,460.00

x Medicis Pharmaceutical Corporation $8,100.00 $4,500.00 $0.00 $12,600.00

x MedImmune, LLC $2,880.00 $4,500.00 $0.00 $7,380.00

x Merck & Co., Inc. $9,960.00 $30,500.00 $50,200.00 $90,660.00

x Merz Pharmaceuticals, LLC $4,620.00 $9,225.00 $495.00 $14,340.00

x Microlife USA, Inc. $4,620.00 $10,150.00 $0.00 $14,770.00

x MiddleBrook Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Midlothian Laboratories, a division of Hi-Tech Pharmacal $0.00 $4,500.00 $0.00 $4,500.00

x Mylan Pharmaceuticals $9,960.00 $50,800.00 $25,000.00 $85,760.00

x NeilMED Pharmaceuticals, Inc. $2,880.00 $6,000.00 $0.00 $8,880.00

x Nephron Pharmaceuticals Corporation $2,880.00 $4,500.00 $0.00 $7,380.00

x Nnodum Pharmaceuticals $2,880.00 $4,500.00 $0.00 $7,380.00

x Novartis Consumer Health, Inc. (OTC N.A.) $9,960.00 $64,250.00 $15,000.00 $89,210.00

x Novartis Pharmaceuticals Corporation $9,960.00 $32,900.00 $45,000.00 $87,860.00

x Novartis Vaccines $2,880.00 $23,000.00 $5,000.00 $30,880.00

x Novo Nordisk Inc. $9,960.00 $30,500.00 $14,400.00 $54,860.00

x OBAGI Medical Products $1,920.00 $4,500.00 $0.00 $6,420.00

Page 20: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2008

x Omron Healthcare Inc. $9,960.00 $25,625.00 $0.00 $35,585.00

x Ortho-McNeil-Janssen Pharmaceuticals, Inc. $9,960.00 $30,500.00 $59,000.00 $99,460.00

x Otsuka America Pharmaceutical, Inc. $2,880.00 $0.00 $10,000.00 $12,880.00

x Paddock Laboratories, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Par Pharmaceutical, Inc. $9,960.00 $40,700.00 $0.00 $50,660.00

x ParMed Pharmaceuticals $2,880.00 $4,500.00 $0.00 $7,380.00

x Patriot Pharmaceuticals LLC $2,880.00 $4,500.00 $15,500.00 $22,880.00

x Perrigo Company $9,960.00 $59,500.00 $20,000.00 $89,460.00

x Perrigo Pharmaceuticals Company $9,960.00 $17,900.00 $0.00 $27,860.00

x Pfizer Inc, Worldwide Pharmaceuticals $9,960.00 $35,500.00 $40,200.00 $85,660.00

x Pharmaceutical Associates, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x PharmaSmart International $2,880.00 $9,400.00 $0.00 $12,280.00

x Philips Respironics, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Pinellas Pharmaceuticals, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Procter & Gamble Health Care Products $9,960.00 $0.00 $0.00 $9,960.00

x Purdue Pharma L.P. $9,960.00 $43,950.00 $495.00 $54,405.00

x Ranbaxy Inc. $9,960.00 $19,400.00 $20,000.00 $49,360.00

x Reliant Pharmaceuticals Inc. $9,960.00 $0.00 $0.00 $9,960.00

x Rising Pharmaceuticals, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x River's Edge Pharmaceuticals, LLC $2,880.00 $4,500.00 $0.00 $7,380.00

x Roche Diagnostics $9,960.00 $24,100.00 $15,000.00 $49,060.00

x Roche Laboratories, Inc. $9,960.00 $14,100.00 $9,500.00 $33,560.00

x Roxane Laboratories (A Boehringer Ingelheim Co.) $9,960.00 $20,500.00 $0.00 $30,460.00

x Salix Pharmaceuticals, Inc. $9,960.00 $20,500.00 $0.00 $30,460.00

x Sandoz $9,960.00 $63,900.00 $84,250.00 $158,110.00

x Sandoz Canada $2,500.00 $0.00 $5,000.00 $7,500.00

x sanofi-aventis $9,960.00 $19,400.00 $35,000.00 $64,360.00

x Schering-Plough $9,960.00 $29,100.00 $0.00 $39,060.00

x Sciele Pharma, Inc $9,960.00 $4,500.00 $0.00 $14,460.00

x Security Equipment Corporation $2,880.00 $4,510.00 $750.00 $8,140.00

x Sepracor Inc. $9,960.00 $14,500.00 $0.00 $24,460.00

x Shire US Inc. $9,960.00 $0.00 $0.00 $9,960.00

x SkinMedica, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Solvay Pharmaceuticals, Inc. $9,960.00 $9,400.00 $0.00 $19,360.00

x Stiefel, a GSK Company $2,880.00 $38,445.00 $0.00 $41,325.00

x Takeda Pharmaceuticals North America, Inc. $9,960.00 $30,700.00 $60,800.00 $101,460.00

x TAP Pharmaceuticals Inc. $9,960.00 $0.00 $0.00 $9,960.00

Page 21: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2008

x Taro Pharmaceuticals U.S.A., Inc. $8,100.00 $65,975.00 $0.00 $74,075.00

x Teva Pharmaceuticals $9,960.00 $81,300.00 $44,700.00 $135,960.00

x Ther-Rx Corporation $8,100.00 $4,500.00 $0.00 $12,600.00

x Torrent Pharma Inc. $960.00 $0.00 $0.00 $960.00

x Triax Pharmaceuticals $4,620.00 $0.00 $0.00 $4,620.00

x UCB, Inc. $9,960.00 $20,500.00 $15,000.00 $45,460.00

x Upsher-Smith Laboratories, Inc. $9,960.00 $34,000.00 $41,000.00 $84,960.00

x URL Pharma $9,960.00 $19,400.00 $29,500.00 $58,860.00

x VaxServe $9,960.00 $4,500.00 $0.00 $14,460.00

x VersaPharm $2,880.00 $4,500.00 $0.00 $7,380.00

x Victory Pharma, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Vision Pharma LLC $2,880.00 $4,500.00 $0.00 $7,380.00

x Warner Chilcott $9,960.00 $4,500.00 $0.00 $14,460.00

x Watson Pharma, Inc. $9,960.00 $65,550.00 $0.00 $75,510.00

x West-ward Pharmaceutical Corp. $4,620.00 $4,500.00 $0.00 $9,120.00

x Wockhardt USA, Inc./Morton Grove Pharmaceuticals $2,880.00 $19,400.00 $0.00 $22,280.00

x Wyeth Pharmaceuticals $9,960.00 $40,700.00 $106,750.00 $157,410.00

x Xanodyne Pharmaceutical, Inc. $9,960.00 $9,400.00 $0.00 $19,360.00

x Zydus Pharmaceuticals (USA) Inc. $4,620.00 $20,500.00 $0.00 $25,120.00

Subtotal - Rx Companies $1,067,620.00 $2,861,905.00 $1,479,585.00 $5,409,110.00

X Abbott Medical Optics, Inc. $9,960.00 $33,025.00 $0.01 $42,985.01

X Advanced Vision Research $4,620.00 $0.00 $0.00 $4,620.00

X Alaven Pharmaceutical LLC $4,620.00 $5,350.00 $795.00 $10,765.00

X ALVA-AMCO Pharmacal Cos., Inc. $2,880.00 $21,470.00 $495.00 $24,845.00

X Amerifit Brands $9,960.00 $26,475.00 $0.00 $36,435.00

X Ansell Healthcare Products LLC $4,620.00 $14,440.00 $0.00 $19,060.00

X B.F. Ascher & Company, Inc. $2,880.00 $0.00 $0.00 $2,880.00

X Bayer HealthCare, Consumer Care $9,960.00 $83,350.00 $110,500.00 $203,810.00

X BD Diabetes Care $9,960.00 $29,550.00 $400.00 $39,910.00

X Bionorica, LLC $1,440.00 $10,575.00 $1,500.00 $13,515.00

X Boehringer Ingelheim Consumer Health Care $9,960.00 $32,600.00 $0.00 $42,560.00

X Cadbury North America $9,960.00 $24,420.00 $1,000.00 $35,380.00

X Chattem, Inc. $9,960.00 $32,600.00 $0.00 $42,560.00

X CIBA Vision Corporation $9,960.00 $0.00 $10,000.00 $19,960.00

X Combe Incorporated $9,960.00 $25,200.00 $0.00 $35,160.00

X Fleet Laboratories $9,960.00 $10,150.00 $0.00 $20,110.00

Page 22: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2008

X Kareway Product Inc. $1,440.00 $10,150.00 $795.00 $12,385.00

X Kobayashi Healthcare, LLC $2,880.00 $0.00 $0.00 $2,880.00

X Lil' Drug Store Products, Inc. $4,620.00 $11,000.00 $0.00 $15,620.00

X Majestic Drug Co., Inc. $2,880.00 $4,725.00 $1,490.00 $9,095.00

X Merix Pharmaceutical Corp. $2,880.00 $10,575.00 $0.00 $13,455.00

X Mission Pharmacal Co. $4,620.00 $4,300.00 $0.00 $8,920.00

X Navajo Manufacturing Co. $2,880.00 $15,200.00 $0.00 $18,080.00

X OHM Laboratories, Inc. $8,100.00 $10,150.00 $0.00 $18,250.00

X Prestige Brands, Inc., Medtech Products Division $9,960.00 $10,150.00 $0.00 $20,110.00

Procter & Gamble Company $9,960.00 $99,250.00 $39,500.00 $148,710.00

X Procter & Gamble Beauty Care Products $9,960.00 $0.00 $0.00 $9,960.00

X Reckitt Benckiser $0.00 $20,550.00 $0.00 $20,550.00

X Ricola USA, Inc. $8,100.00 $31,590.00 $495.00 $40,185.00

X Schering-Plough Consumer Health Care $9,960.00 $76,100.00 $26,000.00 $112,060.00

X Similasan Corporation $4,620.00 $10,000.00 $0.00 $14,620.00

X Sinclair Pharmacal Co., Inc. $2,640.00 $0.00 $0.00 $2,640.00

X Tec Laboratories, Inc. $2,880.00 $4,085.00 $0.00 $6,965.00

X Tender Corporation $2,880.00 $4,725.00 $0.00 $7,605.00

X The Mentholatum Company $9,960.00 $32,600.00 $0.00 $42,560.00

X The Triad Group, Inc. $2,880.00 $10,150.00 $0.00 $13,030.00

X TriDerma MD® $2,880.00 $0.00 $0.00 $2,880.00

X W.F. Young, Inc. $2,880.00 $4,300.00 $995.00 $8,175.00

X WellSpring Pharmaceutical Corporation $0.00 $0.00 $795.00 $795.00

X Wyeth Consumer Healthcare $9,960.00 $77,350.00 $51,750.00 $139,060.00

Subtotal - OTC Companies $240,480.00 $796,155.00 $246,510.01 $1,283,145.01

TOTAL $1,308,100.00 $3,658,060.00 $1,726,095.01 $6,692,255.01

Page 23: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2009

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x A&D Medical - LifeSource $2,880.00 $11,875.00 $0.00 $14,755.00

x Abbott - Pharmaceutical Products Division $9,960.00 $60,700.00 $10,000.00 $80,660.00

x Abbott Diabetes Care $8,100.00 $19,400.00 $0.00 $27,500.00

x Accera, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Actavis $9,960.00 $40,700.00 $5,500.00 $56,160.00

x Alaven Consumer Healthcare, Inc. $2,160.00 $1,725.00 $0.00 $3,885.00

x Alcon Laboratories, Inc. $9,960.00 $28,700.00 $0.00 $38,660.00

x Allergan Inc. $9,960.00 $29,600.00 $0.00 $39,560.00

x Alpharma Pharmaceuticals LLC $9,960.00 $0.00 $0.00 $9,960.00

x Amerigen Pharmaceuticals, Inc. $2,880.00 $6,500.00 $0.00 $9,380.00

x Amgen Inc. $9,960.00 $4,500.00 $0.00 $14,460.00

x Amneal Pharmaceuticals $4,620.00 $30,500.00 $0.00 $35,120.00

x Amphastar Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Amylin Pharmaceuticals, Inc. $9,960.00 $9,400.00 $0.00 $19,360.00

x Anchen Pharmaceuticals, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Apotex Corp. $9,960.00 $49,100.00 $10,000.00 $69,060.00

x Apothecary Products, Inc. $8,100.00 $23,175.00 $0.00 $31,275.00

x AR Scientific, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x ARKRAY USA, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Ascend Therapeutics, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Astellas Pharma US, Inc. $9,960.00 $20,500.00 $0.00 $30,460.00

x AstraZeneca $9,960.00 $80,400.00 $10,000.00 $100,360.00

x Aurobindo Pharma USA, Inc. $8,100.00 $19,400.00 $0.00 $27,500.00

x Auxilium Pharmaceuticals, Inc. $9,960.00 $0.00 $0.00 $9,960.00

x Axcan Pharma US, Inc. $9,960.00 $9,400.00 $0.00 $19,360.00

x Banner $1,680.00 $8,600.00 $0.00 $10,280.00

x Barr Laboratories, Inc. $9,960.00 $0.00 $0.00 $9,960.00

x Bayer HealthCare, Diabetes Care $9,960.00 $21,900.00 $0.00 $31,860.00

x Bayer HealthCare, Pharmaceuticals $4,620.00 $50,800.00 $0.00 $55,420.00

x Beutlich LP Pharmaceuticals $2,400.00 $6,025.00 $995.00 $9,420.00

x Biovail Pharmaceuticals Inc. $4,620.00 $0.00 $0.00 $4,620.00

x Boca Medical Products, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Boehringer Ingelheim Pharmaceuticals, Inc. $9,960.00 $39,600.00 $10,000.00 $59,560.00

x Braintree Laboratories, Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x Breckenridge Pharmaceutical, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x Brookstone Pharmaceuticals, LLC $2,880.00 $4,500.00 $0.00 $7,380.00

x Cadista Pharmaceuticals Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x Can-Am Care, LLC, An Access Product Marketing Company $4,620.00 $25,950.00 $0.00 $30,570.00

x Caraco Pharmaceutical Laboratories, Ltd. $9,960.00 $14,100.00 $25,000.00 $49,060.00

x Celgene Corporation $9,960.00 $4,500.00 $0.00 $14,460.00

x Centocor Ortho Biotech, LLC $9,960.00 $0.00 $0.00 $9,960.00

Page 24: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2009

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x Colgate Oral Pharmaceuticals $4,620.00 $4,500.00 $0.00 $9,120.00

x Columbia Laboratories, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x CorePharma, LLC $4,620.00 $13,600.00 $0.00 $18,220.00

x Coria Laboratories, Ltd. $8,100.00 $8,800.00 $0.00 $16,900.00

x Cornerstone Therapeutics $2,880.00 $4,500.00 $0.00 $7,380.00

x Covidien - Mallinckrodt $9,960.00 $64,800.00 $10,000.00 $84,760.00

x Cypress Pharmaceutical, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Daiichi Sankyo, Inc. $9,960.00 $9,400.00 $200.00 $19,560.00

x Depomed, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Dey, L.P. $1,200.00 $4,500.00 $0.00 $5,700.00

x Dr. Reddy's Laboratories, Inc. $8,100.00 $29,550.00 $0.00 $37,650.00

x Drive Medical Design & Manufacturing $2,880.00 $7,000.00 $0.00 $9,880.00

x Eisai Inc. $9,960.00 $30,500.00 $0.00 $40,460.00

x EMD Serono, Inc. $9,960.00 $4,500.00 $0.00 $14,460.00

x Endo Pharmaceuticals Inc. $9,960.00 $30,700.00 $0.00 $40,660.00

x ETHEX Corporation $9,960.00 $20,510.00 $0.00 $30,470.00

x Eurand Pharmaceuticals, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Falcon Pharmaceuticals, Ltd. $8,100.00 $14,100.00 $0.00 $22,200.00

x Fleming Pharmaceuticals $4,620.00 $0.00 $0.00 $4,620.00

x Forest Pharmaceuticals, Inc. $9,960.00 $24,100.00 $20,000.00 $54,060.00

x Fougera $9,960.00 $49,800.00 $55,500.00 $115,260.00

x G & W Laboratories, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Galderma Laboratories, L.P. $9,960.00 $30,275.00 $0.00 $40,235.00

x GAVIS Pharmaceuticals, LLC $1,680.00 $4,500.00 $0.00 $6,180.00

x Genentech $2,880.00 $0.00 $0.00 $2,880.00

x Genzyme Corporation $2,880.00 $4,500.00 $0.00 $7,380.00

x Gilead Sciences $9,960.00 $0.00 $0.00 $9,960.00

x Glades Pharmaceuticals, LLC $4,620.00 $9,400.00 $0.00 $14,020.00

x GlaxoSmithKline $9,960.00 $58,200.00 $15,200.00 $83,360.00

x Glenmark Generics Inc., USA $9,960.00 $9,400.00 $5,750.00 $25,110.00

x Global Pharmaceuticals, a div. of Impax Laboratories, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x Graceway Pharmaceuticals, LLC $9,960.00 $4,500.00 $0.00 $14,460.00

x Greenstone LLC $4,620.00 $29,100.00 $0.00 $33,720.00

x Harris Pharmaceutical, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Heritage Pharmaceuticals Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x Hi-Tech Pharmacal Co., Inc./Health Care Products Division $2,880.00 $9,400.00 $0.00 $12,280.00

x Home Diagnostics, Inc. $4,620.00 $40,650.00 $0.00 $45,270.00

x Inspire $4,620.00 $4,500.00 $0.00 $9,120.00

x Intendis, Inc. $8,100.00 $0.00 $0.00 $8,100.00

x Johnson & Johnson Healthcare Products $9,960.00 $0.00 $0.00 $9,960.00

x Karalex Pharma, LLC $1,920.00 $4,500.00 $0.00 $6,420.00

Page 25: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2009

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x King Pharmaceuticals $9,960.00 $4,500.00 $0.00 $14,460.00

x Kowa Pharmaceuticals America, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x Kremers Urban LLC $9,960.00 $40,000.00 $0.00 $49,960.00

x KVK-TECH, INC. $2,880.00 $4,500.00 $0.00 $7,380.00

x Lannett Company, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Lifeclinic International, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x LifeScan, Inc. A Johnson & Johnson Company $9,960.00 $15,940.00 $0.00 $25,900.00

x Lilly USA, LLC $9,960.00 $73,900.00 $92,700.00 $176,560.00

x Lupin Pharmaceuticals, Inc. $4,620.00 $30,500.00 $0.00 $35,120.00

x Major's Wholesale Medical Supply, LLC (dba Major's Mobisist) $2,640.00 $0.00 $0.00 $2,640.00

x Meda Pharmaceuticals Inc. $9,960.00 $4,500.00 $0.00 $14,460.00

x Medicis Pharmaceutical Corporation $9,960.00 $4,500.00 $0.00 $14,460.00

x MedImmune, LLC $0.00 $450.00 $0.00 $450.00

x Merck & Co., Inc. $9,960.00 $30,500.00 $0.00 $40,460.00

x Merz Pharmaceuticals, LLC $8,100.00 $10,725.00 $995.00 $19,820.00

x Microlife USA, Inc. $4,620.00 $10,150.00 $0.00 $14,770.00

x MiddleBrook Pharmaceuticals, Inc. $2,880.00 $9,400.00 $0.00 $12,280.00

x Midlothian Laboratories, a division of Hi-Tech Pharmacal $2,880.00 $4,500.00 $0.00 $7,380.00

x MTS Medication Technologies $2,880.00 $9,470.00 $0.00 $12,350.00

x Mylan Pharmaceuticals $9,960.00 $50,800.00 $10,000.00 $70,760.00

x NeilMED Pharmaceuticals, Inc. $2,880.00 $10,625.00 $0.00 $13,505.00

x Nephron Pharmaceuticals Corporation $2,880.00 $4,500.00 $0.00 $7,380.00

x NextWave Pharmaceuticals - OTC Division $2,640.00 $5,450.00 $995.00 $9,085.00

x Nnodum Pharmaceuticals $0.00 $4,500.00 $0.00 $4,500.00

x Novartis Consumer Health, Inc. (OTC N.A.) $9,960.00 $73,500.00 $17,500.00 $100,960.00

x Novartis Ophthalmics $4,620.00 $0.00 $5,000.00 $9,620.00

x Novartis Pharmaceuticals Corporation $9,960.00 $43,000.00 $47,500.00 $100,460.00

x Novartis Vaccines $2,880.00 $23,100.00 $5,000.00 $30,980.00

x Novo Nordisk Inc. $9,960.00 $30,500.00 $0.00 $40,460.00

x Nutramax Laboratories Inc. $2,880.00 $10,150.00 $0.00 $13,030.00

x OBAGI Medical Products $2,880.00 $0.00 $0.00 $2,880.00

x Omron Healthcare Inc. $9,960.00 $25,200.00 $0.00 $35,160.00

x Ortho-McNeil-Janssen Pharmaceuticals, Inc. $9,960.00 $30,500.00 $25,000.00 $65,460.00

x Otsuka America Pharmaceutical, Inc. $2,880.00 $0.00 $22,500.00 $25,380.00

x Paddock Laboratories, Inc. $2,880.00 $4,500.00 $0.00 $7,380.00

x Par Pharmaceutical, Inc. $9,960.00 $30,500.00 $0.00 $40,460.00

x ParMed Pharmaceuticals $4,620.00 $14,000.00 $0.00 $18,620.00

x Patriot Pharmaceuticals LLC $8,100.00 $4,500.00 $10,000.00 $22,600.00

x Perrigo Company $9,960.00 $44,355.00 $20,000.00 $74,315.00

x Perrigo Pharmaceuticals Company $9,960.00 $15,010.00 $0.00 $24,970.00

x Pfizer Inc, Worldwide Pharmaceuticals $9,960.00 $45,500.00 $20,000.00 $75,460.00

Page 26: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2009

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x Pharmaceutical Associates, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x PharmaSmart International $2,880.00 $9,400.00 $0.00 $12,280.00

x Philips Respironics, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Pinellas Pharmaceuticals, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Procter & Gamble Health Care Products $9,960.00 $0.00 $0.00 $9,960.00

x Purdue Pharma L.P. $9,960.00 $44,250.00 $0.00 $54,210.00

x Ranbaxy Inc. $9,960.00 $19,400.00 $10,000.00 $39,360.00

x Revive Personal Products Company $2,400.00 $0.00 $0.00 $2,400.00

x Rising Pharmaceuticals, Inc. $4,620.00 $9,400.00 $0.00 $14,020.00

x River's Edge Pharmaceuticals, LLC $2,880.00 $4,500.00 $0.00 $7,380.00

x Roche Diagnostics $9,960.00 $24,100.00 $20,000.00 $54,060.00

x Roche Laboratories, Inc. $9,960.00 $23,600.00 $0.00 $33,560.00

x Roxane Laboratories (A Boehringer Ingelheim Co.) $9,960.00 $20,500.00 $0.00 $30,460.00

x Salix Pharmaceuticals, Inc. $9,960.00 $20,500.00 $0.00 $30,460.00

x Sandoz $9,960.00 $78,000.00 $57,700.00 $145,660.00

x Sandoz Canada $2,500.00 $0.00 $0.00 $2,500.00

x sanofi-aventis $9,960.00 $19,400.00 $50,000.00 $79,360.00

x Schering-Plough $9,960.00 $24,100.00 $0.00 $34,060.00

x Sciele Pharma, Inc $9,960.00 $4,500.00 $0.00 $14,460.00

x Sepracor Inc. $9,960.00 $14,500.00 $0.00 $24,460.00

x Shire US Inc. $9,960.00 $18,500.00 $0.00 $28,460.00

x SkinMedica, Inc. $4,620.00 $4,500.00 $0.00 $9,120.00

x Solvay Pharmaceuticals, Inc. $9,960.00 $9,400.00 $0.00 $19,360.00

x Stiefel, a GSK Company $2,880.00 $38,390.00 $0.00 $41,270.00

x Strativa Pharmaceuticals $5,400.00 $0.00 $0.00 $5,400.00

x Takeda Pharmaceuticals North America, Inc. $9,960.00 $30,700.00 $15,000.00 $55,660.00

x Taro Pharmaceuticals U.S.A., Inc. $8,100.00 $65,550.00 $0.00 $73,650.00

x Teva Pharmaceuticals $9,960.00 $92,600.00 $80,215.00 $182,775.00

x Ther-Rx Corporation $9,960.00 $4,500.00 $0.00 $14,460.00

x Torrent Pharma Inc. $1,920.00 $4,500.00 $0.00 $6,420.00

x Triax Pharmaceuticals $4,620.00 $0.00 $0.00 $4,620.00

x UCB, Inc. $9,960.00 $14,000.00 $15,000.00 $38,960.00

x Upsher-Smith Laboratories, Inc. $9,960.00 $47,500.00 $26,000.00 $83,460.00

x URL Pharma $9,960.00 $28,900.00 $10,000.00 $48,860.00

x VaxServe $9,960.00 $14,000.00 $0.00 $23,960.00

x VersaPharm $4,620.00 $9,400.00 $200.00 $14,220.00

x Victory Pharma, Inc. $8,100.00 $4,500.00 $0.00 $12,600.00

x Vision Pharma LLC $2,880.00 $4,500.00 $0.00 $7,380.00

x Warner Chilcott $9,960.00 $4,500.00 $0.00 $14,460.00

x Watson Pharma, Inc. $9,960.00 $65,550.00 $0.00 $75,510.00

x West-ward Pharmaceutical Corp. $4,620.00 $4,500.00 $0.00 $9,120.00

Page 27: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2009

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x Wockhardt USA, Inc./Morton Grove Pharmaceuticals $4,620.00 $19,400.00 $0.00 $24,020.00

x Wyeth Pharmaceuticals $9,960.00 $31,520.00 $40,000.00 $81,480.00

x Xanodyne Pharmaceutical, Inc. $9,960.00 $4,500.00 $0.00 $14,460.00

x Zogenix, Inc. $1,200.00 $4,500.00 $0.00 $5,700.00

x Zydus Pharmaceuticals (USA) Inc. $4,620.00 $20,500.00 $0.00 $25,120.00

Subtotal - Rx Companies $1,103,320.00 $2,830,020.00 $779,450.00 $4,712,790.00

x Abbott Medical Optics, Inc. $4,620.00 $32,600.00 $0.00 $37,220.00

x Advanced Vision Research $4,620.00 $575.00 $0.00 $5,195.00

x Alaven Pharmaceutical LLC $4,620.00 $4,500.00 $0.00 $9,120.00

x ALVA-AMCO Pharmacal Cos., Inc. $2,880.00 $31,470.00 $995.00 $35,345.00

x Amerifit Brands $9,960.00 $24,440.00 $0.00 $34,400.00

x Ansell Healthcare Products LLC $4,620.00 $15,775.00 $0.00 $20,395.00

x B.F. Ascher & Company, Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Bayer HealthCare, Consumer Care $9,960.00 $83,275.00 $113,500.00 $206,735.00

x BD Diabetes Care $9,960.00 $39,050.00 $200.00 $49,210.00

x Bionorica, LLC $2,880.00 $10,725.00 $0.00 $13,605.00

x Boehringer Ingelheim Consumer Health Care $9,960.00 $32,600.00 $0.00 $42,560.00

x Bristol-Myers Squibb, US Pharmaceutical Group $9,960.00 $50,200.00 $25,000.00 $85,160.00

x Cadbury North America $9,960.00 $27,695.00 $0.00 $37,655.00

x Chattem, Inc. $9,960.00 $32,600.00 $0.00 $42,560.00

x CIBA Vision Corporation $9,960.00 $0.00 $12,500.00 $22,460.00

x Combe Incorporated $9,960.00 $25,200.00 $0.00 $35,160.00

x Essential Home OTCs, LLC $1,440.00 $4,300.00 $0.00 $5,740.00

x Fleet Laboratories $9,960.00 $11,300.00 $0.00 $21,260.00

x Health Enterprises, Inc. $2,880.00 $6,600.00 $995.00 $10,475.00

x Hisamitsu America, Inc. $2,880.00 $4,875.00 $0.00 $7,755.00

x Hygenic Corporation $1,440.00 $500.00 $0.00 $1,940.00

x J. R. Watkins, Incorporated $1,440.00 $500.00 $0.00 $1,940.00

x Kareway Product Inc. $2,880.00 $9,645.00 $0.00 $12,525.00

x Kobayashi Healthcare, LLC $2,880.00 $0.00 $0.00 $2,880.00

x Lil' Drug Store Products, Inc. $4,620.00 $10,150.00 $0.00 $14,770.00

x Majestic Drug Co., Inc. $2,880.00 $4,875.00 $995.00 $8,750.00

x Merix Pharmaceutical Corp. $2,880.00 $10,725.00 $0.00 $13,605.00

x Mission Pharmacal Co. $2,880.00 $4,300.00 $0.00 $7,180.00

x Navajo Manufacturing Co. $2,880.00 $11,300.00 $0.00 $14,180.00

x OHM Laboratories, Inc. $8,100.00 $10,150.00 $0.00 $18,250.00

x Prestige Brands, Inc., Medtech Products Division $9,960.00 $20,150.00 $0.00 $30,110.00

x Procter & Gamble Company $9,960.00 $114,250.00 $30,000.00 $154,210.00

x Procter & Gamble Beauty Care Products $9,960.00 $0.00 $0.00 $9,960.00

x Reckitt Benckiser $9,960.00 $39,200.00 $0.00 $49,160.00

Page 28: The Wall Street Journal - Chuck Grassley · 2011. 5. 4. · report to the Secretary their financial relationship with:…physician groups and other prescribers…patient organizations;

NACDS 2009

Rx OTC Company Dues Exhibit Meeting Total

Space Sponsorship Funding

x Ricola USA, Inc. $8,100.00 $20,220.00 $995.00 $29,315.00

x Robinson Pharma Inc. $1,920.00 $10,150.00 $0.00 $12,070.00

x Schering-Plough Consumer Health Care $9,960.00 $64,650.00 $24,000.00 $98,610.00

x Similasan Corporation $8,100.00 $10,000.00 $0.00 $18,100.00

x Sinclair Pharmacal Co., Inc. $2,880.00 $0.00 $0.00 $2,880.00

x Tec Laboratories, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x Tender Corporation $2,880.00 $4,875.00 $0.00 $7,755.00

x The Mentholatum Company $9,960.00 $32,600.00 $0.00 $42,560.00

x The Triad Group, Inc. $2,880.00 $10,150.00 $0.00 $13,030.00

x TriDerma MD® $2,880.00 $0.00 $0.00 $2,880.00

x W.F. Young, Inc. $2,880.00 $4,300.00 $0.00 $7,180.00

x WellSpring Pharmaceutical Corporation $2,880.00 $13,800.00 $0.00 $16,680.00

Subtotal - OTC Companies $264,840.00 $848,570.00 $209,180.00 $1,322,590.00

Total $1,368,160.00 $3,678,590.00 $988,630.00 $6,035,380.00